Oncology Conferences|Radiology conferences|Asia Pacific conferences|japan conferences|Osaka|Japan|2018

Theme: Cancer Radiology - The Future Shape of Specialty

Clinical Oncology-2018

clinical oncology -2018

Clinical Oncology-2018

ConferenceSeries Ltd is overwhelmed to welcome all the interested participants to its Global conference on Oncology and Radiology during May 28-29, 2018 Osaka, Japan

The conference will be organized around the theme: Cancer Radiology - The Future Shape of Specialty .This is an event that brings together active researchers, intellectuals, academicians, students, contributors and industrialists to exchange ideas communicate and discuss research findings on new advancements in all kinds of available anticancer therapies worldwide .This is a two day multidisciplinary meeting covering all aspects of Cancer Therapies and Radiation Oncology, including clinical service delivery, management, informatics and research.

Radiation Oncology is a medical specialty that involves treating cancer with radiation. Doctors who specialize in treating cancer with radiation (radiation oncologists) use radiation therapy to treat a wide variety of cancers. Radiation therapy uses carefully targeted and regulated doses of high-energy radiation to kill cancer cells. Radiation kills cancer cells by damaging the chromosomes and DNA so that the cells can no longer divide and the tumor can't grow. The discussion extends to all available Anti-cancer Therapies like Surgical Therapy, Chemotherapy, Adjuvant Therapy, Neoadjuvant Therapy, Immunotherapy, Hormonal Therapy, Proton Beam Therapy, Phototherapy, Stem Cell Therapy and Alternative Medicine.

Conference Series along with its subsidiary ConferenceSeries Ltd which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe . Conference series hosts numerous Cancer Conferences,Cancer meeting, global cancer conference, European Oncology Conferences, Surgical oncology like skin cancer conference, breast cancer conference, liver cancer conference, lung cancer meetings, and Oncology Conferences where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions and which helps get possibilities for treating the diseases with new era, technology and research.

Why to attend?

With members from around the world focused on learning about Oncologists; this is your best opportunity to reach the largest assemblage of participants from the Oncologists community, oncology society, European oncology conferences, American oncology society. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Oncology are hallmarks of this conference.

Target Audience

· Oncologists

· Radiologists

· Pathologists

· Hematologists

· Academicians

· Research Scholars

· Students

· Hematology Associations & Societies

· Business Entrepreneurs

· Software Developing Companies

· Medical Devices Companies

· Biomedical Companies

· Biotechnology Companies

· Data Management Companies

Track 1: Radiation Oncology

The branch of Oncology dealing with Radiation therapy is termed as Radiation Oncology. The Radiotherapy is broadly segmented into Teleradiotherapy, Brachy-radiotherapy and Metabolic Radiotherapy. Tele-radiotherapy, also called as External transcutaneous / distant radiotherapy, is a method in which the radiation source is situated at a certain distance from the tissue to be treated. Brachytherapy, also termed as Short direct radiotherapy /Curitherapy, is a method in which radiation source can be placed in contact with the tumor or it can be implanted in the tumor. Curative radiotherapy is indicated to be used in: Sticker’s sarcoma, Mastocytomas with particular locations, such as ears, nose, extremities, eyelids; Nasal cavity adenocarcinoma and Anal gland adenocarcinoma. Stereotactic radiosurgery is a single-day procedure for treating small intracranial lesions. Metabolic radiotherapy represents the administration of isotopes or isotope carrying molecules that selectively concentrate in a certain tissue into which they enter as metabolites. For Example; iodine-131is used in treating Thyroid cancer; phosphorus-32 is used in treating Myeloproliferative disorders.

22^ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan; 15th Global Annual Oncologists Meeting, October 19-20, 2017 New York, USA; 9th International Cancer Biomarkers Conference, October 26-28, 2017 Osaka,Japan; Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers ,August 23-24, 2017 Birmingham, UK; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, International Conference on Epigenetics 2017, November 13-15, 2017

Track 2: Clinical Oncology

Clinical oncology embraces the non-surgical aspect of oncology. It covers both the therapeutic administration of ionizing radiation i.e. radiotherapy and cytotoxic chemotherapy. Clinical oncology is a major participant in any multi-disciplinary team, which would meet regularly to discuss site specific cases of tumours. Other members would be site specific surgeon, palliative care physician, radiologist, pathologist, specialist nursing staff and appropriate haematologist and medical oncologist. Radiotherapy is the administration of ionizing radiation predominantly by external beam (teletherapy) but is also using the more technical operative implantation of interstitial sources, which are often after loaded with radioactive material, e.g. Iridium. There is, therefore, close liaison with postgraduate physicists and scope for great technological understanding with computer planning, etc. Consultants are increasingly site specialized and are based in a cancer centre often visiting peripheral cancer units.
Clinical oncology is very patient orientated. This specialty gives the opportunity of developing clinical and scientific skills with great potential for academic and clinical research. Furthermore, there are increasing opportunities to take part in National and International Research Trials.
Clinical oncology is a specialist discipline within radiology. The primary role of the clinical oncologist is the completion of the radiation treatment for cancer patients. Radiation is used to kill the cancer cells within the body. The extent of treatment depends on the type of cancer, degree of progression, and the timing of the diagnosis. Typically, cancer patients who have late stage cancer are not ideal candidates for radiation therapy.

Track 3 : Oncology Nursing

Oncology is a standout amongst the most Focused zone in Cancer Treatments. For an Oncologist or Oncology Nurse, to locate an appropriate words to cheer a man who enduring with sickness. The specific medical caretaker is an enrolled nurture whose essential concentration in tumor mind. This medical caretaker has development strength learning, expertise, and practices in a domain where the lion's share of element has determination of tumor or at danger of advance malignancy. The advanced Oncology Nurse is master’s prepared nurse with learning and capacity in a range of malignancy nursing. All medical caretakers move along a way from learners to master. It is perceived that, paying little respect to regardless of the possibility that a generalist, specific oncology or propelled Oncology Nurse, every individual medical attendant will encounter this way from amateurs to master.

Track 4: Cancer Therapies

Cancer rates are daily increasing particularly in the developed world. Many cancers are associated with longevity, and as life expectancy increase the risk on patients and payers will increase. Major advances in cellular biology, genetics, pharmacology and immunology in the past ten years are beginning to be translated into progress in cancer treatment. This progress is manifested by new cell killing drugs which have recently entered clinical practice. Tumour angiogenesis as a target is being studied in several clinical trials. The emerging field of genomics and gene expression micro-arrays will provide extensive information about the biology of cancers. This is the most prestigious conference across all the Cancer Conferences and Oncology Conferences

Track 5 : Organ-Defined Cancers:

There are about 200 different types of cancer, but they all start as a result of the out-of-control growth of abnormal cells. Cancers are classified in two ways: by the type of tissue in which the cancer originates (histological classification) or by the location or organ in the body where the cancer first developed.

Track 6 : Stages of cancer

The cells that generate cancer cells begin to divide more vigorously than usual. As the cancer progresses, tissue that has become malignant continues to alter and become more malignant. The tumour cells become differentiated and the body’s regulatory system is no longer able to control the changes taking place, and so eventually the cancerous tissue begins to spread.Cancer begins to cause damage to the body by growing locally, metastasising in different organs and causing a variety of general symptoms. A malignant tumour can become sizeable at its primary site and harm the normal functioning of the organ in question. The tumour can also displace neighbouring organs, causing pain and pressure symptoms.

Cancer is divided into five stages using the TNM system – 0, I, II, III, IV. Stage 0 means the presence of a small carcinoma in situ that has not spread. Stage IV means cancer that has spread widely or cancer that has metastasised. In some cases the stages have subclasses

Track 7: Cancer Biomarkers

With the emergence of genomic profiling technologies and selective molecular targeted therapies, biomarkers play an increasingly important role in the clinical management of cancer patients. Single gene/protein or multi-gene “signature”-based assays have been introduced to measure specific molecular pathway deregulations that guide therapeutic decision-making as predictive biomarkers. Genome-based prognostic biomarkers are also available for several cancer types for potential incorporation into clinical prognostic staging systems or practice guidelines. However, there is still a large gap between initial biomarker discovery studies and their clinical translation due to the challenges in the process of cancer biomarker development.

Track 8: Cancer Screening Test

Prostate screening tests consist of Digital rectal exam (DRE) and Prostate-specific antigen (PSA) test. Screening increases the capacity of detecting certain cancers early when they are most likely to be curable. Learn what screening tests the American Cancer associations suggests, when you should have them, and how they are covered under some types of cancer therapies. Mammograms are used to analyses breast cancer in women who have no signs or symptoms of the disease. Cancer screening Oncolytic is an exciting, increasingly recognized discipline in cancer research which will be discussed in upcoming cancer conferences.

Track 9: Stem Cell

Stem cells: An undifferentiated cell of a multicellular cell which is capable of giving rise to indefinitely more cells of the same type, and from which certain other kinds of cell arise by differentiation. Stem cells have the ability to differentiate into specific cell types. The two defining characteristics of a stem cell are perpetual self-renewal and the ability to differentiate into a specialized adult cell type. There are two major classes of stem cells: pluripotent that can become any cell in the adult body, and multipotent those are restricted to becoming a more limited population of cells.

Track 10: Cancer Biopsy

A biopsy is a method of removing a piece of tissue or a sample of cells from your body so that it can be analyzed in a laboratory. When an entire lump or suspicious area is removed, the method is called an excisional biopsy. When only a piece of tissue is removed with preservation of the histological architecture of the tissue’s cells, the method is called an incisional biopsy or core biopsy. Fine needle aspiration (FNA) is a type of biopsy procedure, most often done on swellings or lumps located just under the skin. Endoscopic biopsy is most often used in gastric cancers to remove the tissues for examination. CT-guided biopsy is a procedure by which the physician uses a very thin needle and a syringe to withdraw a tissue or fluid specimen from an organ or suspected tumor mass. Ultrasound-guided biopsy which involves the removal of cells from a suspicious area within the body using a thin needle and hollow tube called a syringe. Ultrasound is used by the physician to guide the needle to the appropriate area.

Track 11: Alternative Medicine

Alternative medicine or fringe medicine are practices asserted to have the healing effects of medicine however are disproven, problematic, difficult to demonstrate, or just harmful. Alternative medicine has developed in prevalence and is utilized by a critical rate of the populace in numerous nations. While it has widely rebranded itself: from misrepresentation to correlative or integrative pharmaceutical—it advances basically similar practices. In any case, critical medication communications brought about by option treatments may rather contrarily impact medicines, making them less successful, eminently disease treatment. In the UK corresponding treatments are ordinarily made accessible to cancer patients. Alternative medicine has been criticized for being based on misleading statements, deception, pseudoscience, antiscience, extortion, or poor logical philosophy.

Inspite of all these Alternative medicine has few advantages: Many individuals swing to Alternative medicine treatments for pain relief when traditional treatments neglect to work. Alternative medicine offers treatment choices to people who do not have access to pain clinics under their medical coverage arranges, Alternative medicine treatments utilized together with traditional medicinal medications can reduce a portion of the manifestations of cancer, and decrease the antagonistic symptoms of customary restorative medications. Alternative medicine treatments can be less costly than routine therapeutic medicines. As a rule, compelling option treatments have less or no reactions rather than the regular and at times serious impacts of numerous professionally prescribed pharmaceuticals and other routine medicinal medications. Alternative medicine can be valuable to a man's general prosperity, as the approach concentrates on recuperating the psyche, body and soul.

Track 12: Oncologist Meet

The cancer study is called as Oncology. A person who specializes in the study of oncology and treating people with cancer is known as oncologist. An oncologist shows dedicative care towards treatment once a person is suffering from cancer. There are about 2900 oncologists in Germany, and 8000 oncologists in USA, around 9500 oncologists in Europe and 1500 eminent oncologists from different parts of Asia.

Market Analysis for Oncology 2018,Japan

Oncology is the term used for the study of the cancer and it is branch of medicine. Doctor who specializes in the Oncology is known as Oncologist. The vital role of the oncologist is to diagnose the people who are suffering from the cancer and explain the adverse effects during the treatment. There are different types of Oncologists in treating the cancer. Medical Oncologist treats the cancer with the chemotherapy process. Surgical Oncologist involves in the removal of the tumour and the surrounded tissue during the surgery. Radiation Oncologist used to treat the cancer with the Radiation therapy.

Cancer is a common term for a large group of diseases that can affect any organ of the body. Other terms used are malignant tumours and neoplasms. One of the significant features of cancer is the rapid creation of abnormal cells that grow beyond their usual margins, and which can then attack the adjoining parts of the body and spread to other organs. This process is referred to as metastasis. They are the major cause of death from cancer. Tobacco use, alcohol use, unhealthy diet and physical inactivity are the main cancer risk factors worldwide. Chronic infections from hepatitis B (HBV), hepatitis C virus (HCV) and some types of Kaposi’s sarcoma are leading risk factors for cancer in low- and middle-income countries.

Scope and Importance

Cancer is the second leading cause of death worldwide and in all regions of the world. It has undergone a period of dramatic economic, social, and demographic change, resulting in increased life expectancy and prosperity.

Cancer is the leading cause of death in the Dubai. The incidence of all cancers is projected to 20% increase by 2010-2030, primarily due to ageing and also possibly due to increased exposure to risk factors for cancer. Breast cancer is the most common cancer among UAE females (and the most prevalent cancer in both sexes combined), lung cancer, prostate cancer and bowel caners are the most common cancers amongst males but is extremely rare in females, which reflects the prevalence of smoking (23.0% vs. 0.5%, respectively).

According to 2012 statistics approximately 14.1 million cases are reported and 8.2 million deaths are reported. Lung, Liver, Stomach and bowel cancers cause the most common deaths among the worldwide that accounts nearly half of all the cancer deaths. About 70% increasein the cases are to be expected over the next 2 decades. In males 5 most common sites of cancer are diagnosed in 2012 were lung, prostate, colorectal and liver cancers. In females 5 most common sites diagnosed were breast, colorectal, cervix, lung and stomach cancer. Breast cancer, the most common tumor in women, presents a high survival percentage: 83% of patients have survived this type of cancer after five years.

Cervical cancer is the third most commonly diagnosed cancer and the fourth leading cause of cancer death in females’ worldwide, accounting for 9% (529,800) of the total new cancer cases and 8% (275,100) of the total cancer deaths among females. More than 85% of these cases and deaths occur in developing countries.

Lung cancer is one of the most aggressive tumors and survival after five years is very low: only 10% of patients diagnosed with a malignant neoplasm survive for more than five years.

Colorectal cancer (of the colon and rectum), the most common malignant tumors if we group men and women together, presents an average survival rate of 50-55% five years after diagnosis, meaning that half the patients survive this form of cancer.Prostate cancer, today the most common tumors in men, has an increasingly favorable prognosis, with a global survival rate of 76%, which is higher in young adults.

Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years-old.

Oncology Conferences are intended to provide a medium for the communication of results and ideas in the field of cancer science and Treatment regarding to cancers. The conference welcomes contributions in both the basic and clinical aspects of the cancer science and special sections on the Health Care and a forum for Innovative topics related to the cancer science.

Oncologists 2016 will be the best platform for oncologists, radiologists, pathologists, Immunologists researchers working in this field to connect and exchange ideas.

ConferenceSeries Ltd welcomes all the oncologists, radiologists, pathologists, Immunologists research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of the esteemed Oncologists. As this will be the best amalgamation of academia and research involving every aspect and advances in the field of Oncology & cancer. It is open to all types of research methodologies both from academia and industry

Why Japan?

Japan is considered as an important centre for higher education and harbours, healthcare, well reputed and prestigious colleges and Universities. It can be considered as a suitable medium for the relocation of valuable knowledge about research and novel advancements worldwide. The conferences taking part here would promote a variety of scientific ideas among contenders belonging to diverse areas of science and technology. Japanese outcomes for high level medical treatment are generally competitive with that of the US. A comparison of two reports in the New England Journal of Medicine suggest that outcomes for gastro-oesophageal cancer is better in Japan than the US in both patients treated with surgery alone and surgery followed by chemotherapy. Japan excels in the five-year survival rates of colon cancer, lung cancer, pancreatic cancer and liver cancer based on the comparison of a report by the American Association of Oncology and another report by the Japan Foundation for the Promotion of Cancer research. The same comparison shows that the US excels in the five-year survival of rectal cancer, breast cancer, prostate cancer and malignant lymphoma. Surgical outcomes tend to be better in Japan for most cancers while overall survival tend to be longer in the US due to the more aggressive use of chemotherapy in late stage cancers. A comparison of the data from United States Renal Data System (USRDS) 2009 and Japan Reno logy Society 2009 shows that the annual mortality of patients undergoing dialysis in Japan is 13% compared to 22.4% in the US. Five-year survival of patients under dialysis is 59.9% in Japan and 38% in the US.

Cancer Universities in Japan

National Cancer Centre Hospital
Aichi Cancer Centre
Kyoto Prefectural University of Medicine
Tohoku University
Kyoto University
Chiba University
Osaka University

Universities Worldwide

University of Oxford
University of Cambridge
UCL London's Global University
Stanford University
Western University
University of Nottingham
University of Bologna
University of Athens
University of Chicago
University of Washington
University of Rochester
The University of Melbourne
University of Glasgow
Fudan University
Stanford University
University of Minnesota
University of Albert
University of Nebraska
University of Iowa Carver
University of Pennsylvania
South-western University
University of Pittsburgh
University of Helsinki
University of Penn Medicine

Universities in Asia

Osaka University
Tsinghua University
Fudan University
Taipei Medical University
KAIST - Korea Advanced Institute of Science and Technology
Yonsei University
Shanghai Jiao Tong University
Nanyang Technological University (NTU)
Chulalongkorn Universit
Tohoku University
Tokyo Medical and Dental University
Kyushu University
Nagoya University
Hokkaido University
Sungkyunkwan Universit
Indian Institute of Science
University Kebangsaan Malaysia (UKM)
University Saints Malaysia (USM)
Beijing University of Chinese Medicine
National Tsing Hua University

Associations in Japan

The Japanese Breast Cancer Society
The Japanese Cancer Association
Japan Society of Clinical Oncology
Japanese Gastric Cancer Association
The Japanese Society of Hematology
The Japan Lung Cancer Society
Japanese Society of Medical Oncology (JSMO)
The Japanese Society of Paediatric Hematology/Oncology
Japan Primary Care Association

Associations Worldwide

Life South Community Blood Centre
World congress of the International society of Hematology
International society of Hematology
World federation of Haemophilia
European Hematology Associations
Malaysian society of Hematology
Armenian associations of Hematology & Oncology
Japanese society of Hematology
Japan Primary Care Association

Association in Asia Pacific

The Asia-Pacific Urogynecology Association
The Asia-Pacific Cancer Society Training
Asian Cancer Foundation India
The Max Foundation
Childhood Cancer International Netherlands
The Asia Pacific Prostate Society

Pharmaceutics company in Japan

Takeda
Otsuka
Meiji
Daiichi Sankyo
Astellas
Teijin
Chugai
Mitsubishi Tanabe
Kyowa Hakko Kirin
Taisho
Shionogi
Ono
Hisamitsu
Santel
Kyorin
Nichi-Iko
Mochida
Kaken
Sawai
Kissei
Towa
Zeria
Torii
takedaDaito

Cancer hospitals in Japan

St Luke's International Hospital
National Cancer Centre Hospital, Tokyo ,Japan
Japan Red Cross Medical Centre
Shizuoka Cancer Centre
Chiba university hospital

Cancer hospitals worldwide

Leiden University Medical Centre
Royal Cancer Hospital
King’s College Hospital
Clatter bridge Centre for Oncology
Northampton General Hospital
Cambridge University Hospitals
University Hospital Southampton
Central Manchester University Hospitals

Oncology and Radiology conference creates a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing

Speakers and other participants of Oncology Conference get an offer of 30% waiver on publication fee. Do not miss the opportunity of publishing your research at right place and make sure your research reaches the right industry through OPEN ACCESS Journals

Oncology Journals Impact Factors List
Journal Name	Journal Impact Factor*	Citations Report
Journal of Carcinogenesis & Mutagenesis	1.09 2.50 (5 Yr Journal Impact Factor)	Citations Report
Journal of Cancer Science & Therapy	3.09 1.22 (5 Yr Journal Impact Factor)	Citations Report
Journal of Nuclear Medicine & Radiation Therapy	2.15 1.02 (5 Yr Journal Impact Factor)	Citations Report
Journal of Integrative Oncology	1.80 0.74 (5 Yr Journal Impact Factor)	Citations Report
Journal of Clinical Case Reports	0.54 0.47 (5 Yr Journal Impact Factor)	Citations Report
Journal of Leukemia	1.25	Citations Report
OMICS Journal of Radiology	1.13	Citations Report
Chemotherapy: Open Access	1.64	Citations Report
Archives in Cancer Research	0.6	Citations Report
Journal of Clinical & Experimental Oncology	0.264	Citations Report

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	May 28-29, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View